Get my own profile
Public access
View all42 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Frank BreitlingKarlsrueh Institut für TechnologieVerified email at KIT.edu
- Alexander Nesterov-MuellerKarlsruhe Institute of Technology , team leaderVerified email at kit.edu
- Peter SeebergerDirector Max Planck InstituteVerified email at mpikg.mpg.de
- Yuxin LiuMax-Planck Institute of Colloids and InterfacesVerified email at mpikg.mpg.de
- Junfang ZhangResearch Associate, Imperial College LondonVerified email at imperial.ac.uk
- Marylyn Martina AddoProfessor of Emerging Infections, University Clinical Center Hamburg-EppendorfVerified email at uke.de
- Stefan BräseProfessor of Organic Chemistry, Karlsruhe Institute of Technology (KIT)Verified email at kit.edu
- Alexander WelleKarlsruhe Institute for TechnologyVerified email at kit.edu
- Dario MagerGroup Leader, Karlsruhe Institute of TechnologyVerified email at kit.edu
- Christoph RademacherProfessor for Molecular Drug Targeting, University of Vienna, Department of Pharmaceutical SciencesVerified email at univie.ac.at
- Oleksandr SavateevThe Chinese University of Hong Kong; Max Planck Institute of Colloids and InterfacesVerified email at cuhk.edu.hk
- Francesco MuttiAssociate Professor of Biocatalysis & Group Leader BiocatalysisVerified email at uva.nl
- Markus AntoniettiMax Planck Institute of Colloids and Interfaces, DirectorVerified email at mpikg.mpg.de
- Molly StevensProfessor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences Verified email at imperial.ac.uk
Follow
Felix F. Loeffler
Group Leader, Max Planck Institute of Colloids and Interfaces
Verified email at mpikg.mpg.de - Homepage